Home > > > Report Detail

Impact of COVID-19 Outbreak on EPA / DHA/ALA (Omega 3), Global Market Research Report 2020

Publisher Name :
Date: 21-May-2020
No. of pages: 98
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the EPA / DHA/ALA (Omega 3) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the EPA / DHA/ALA (Omega 3) industry.

Segment by Type, the EPA / DHA/ALA (Omega 3) market is segmented into

- Fish Oil

- Algae Oil

Segment by Application

- Dietary Supplements

- Functional Foods & Beverages

- Others

Global EPA / DHA/ALA (Omega 3) Market: Regional Analysis

The EPA / DHA/ALA (Omega 3) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

This report covered in the EPA / DHA/ALA (Omega 3) market report are:

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global EPA / DHA/ALA (Omega 3) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global EPA / DHA/ALA (Omega 3) market include:

- EPAX

- Golden Omega

- TASA

- Omega Protein

- Croda

- KD Pharma

- GC Rieber

- Polaris

- Auqi

Impact of COVID-19 Outbreak on EPA / DHA/ALA (Omega 3), Global Market Research Report 2020

Table of Contents
1 EPA / DHA/ALA (Omega 3) Market Overview
1.1 Product Overview and Scope of EPA / DHA/ALA (Omega 3)
1.2 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Segment by Type
1.2.1 Global EPA / DHA/ALA (Omega 3) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Segment by Application
1.3.1 EPA / DHA/ALA (Omega 3) Sales Comparison by Application: 2020 VS 2026
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Market Size Estimates and Forecasts
1.4.1 Global EPA / DHA/ALA (Omega 3) Revenue 2015-2026
1.4.2 Global EPA / DHA/ALA (Omega 3) Sales 2015-2026
1.4.3 EPA / DHA/ALA (Omega 3) Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on EPA / DHA/ALA (Omega 3) Industry
1.7 COVID-19 Impact: EPA / DHA/ALA (Omega 3) Market Trends
2 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Market Competition by Manufacturers
2.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturers (2015-2020)
2.2 Global EPA / DHA/ALA (Omega 3) Revenue Share by Manufacturers (2015-2020)
2.3 Global EPA / DHA/ALA (Omega 3) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers EPA / DHA/ALA (Omega 3) Manufacturing Sites, Area Served, Product Type
2.5 EPA / DHA/ALA (Omega 3) Market Competitive Situation and Trends
2.5.1 EPA / DHA/ALA (Omega 3) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key EPA / DHA/ALA (Omega 3) Players (Opinion Leaders)
3 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Retrospective Market Scenario by Region
3.1 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
3.3.1 North America EPA / DHA/ALA (Omega 3) Sales by Country
3.3.2 North America EPA / DHA/ALA (Omega 3) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
3.4.1 Europe EPA / DHA/ALA (Omega 3) Sales by Country
3.4.2 Europe EPA / DHA/ALA (Omega 3) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific EPA / DHA/ALA (Omega 3) Market Facts & Figures by Region
3.5.1 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
3.5.2 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.6 Latin America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
3.6.1 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
3.6.2 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
3.7.1 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
3.7.2 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Type
4.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2015-2020)
4.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Type (2015-2020)
4.3 Global EPA / DHA/ALA (Omega 3) Price Market Share by Type (2015-2020)
4.4 Global EPA / DHA/ALA (Omega 3) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Application
5.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
5.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2015-2020)
5.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2015-2020)
6 Company Profiles and Key Figures in EPA / DHA/ALA (Omega 3) Business
6.1 EPAX
6.1.1 Corporation Information
6.1.2 EPAX Description, Business Overview and Total Revenue
6.1.3 EPAX EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 EPAX Products Offered
6.1.5 EPAX Recent Development and Response to COVID-19
6.2 Golden Omega
6.2.1 Golden Omega Corporation Information
6.2.2 Golden Omega Description, Business Overview and Total Revenue
6.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Golden Omega Products Offered
6.2.5 Golden Omega Recent Development and Response to COVID-19
6.3 TASA
6.3.1 TASA Corporation Information
6.3.2 TASA Description, Business Overview and Total Revenue
6.3.3 TASA EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 TASA Products Offered
6.3.5 TASA Recent Development and Response to COVID-19
6.4 Omega Protein
6.4.1 Omega Protein Corporation Information
6.4.2 Omega Protein Description, Business Overview and Total Revenue
6.4.3 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Omega Protein Products Offered
6.4.5 Omega Protein Recent Development and Response to COVID-19
6.5 Croda
6.5.1 Croda Corporation Information
6.5.2 Croda Description, Business Overview and Total Revenue
6.5.3 Croda EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Croda Products Offered
6.5.5 Croda Recent Development and Response to COVID-19
6.6 KD Pharma
6.6.1 KD Pharma Corporation Information
6.6.2 KD Pharma Description, Business Overview and Total Revenue
6.6.3 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 KD Pharma Products Offered
6.6.5 KD Pharma Recent Development and Response to COVID-19
6.7 GC Rieber
6.6.1 GC Rieber Corporation Information
6.6.2 GC Rieber Description, Business Overview and Total Revenue
6.6.3 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GC Rieber Products Offered
6.7.5 GC Rieber Recent Development and Response to COVID-19
6.8 Polaris
6.8.1 Polaris Corporation Information
6.8.2 Polaris Description, Business Overview and Total Revenue
6.8.3 Polaris EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Polaris Products Offered
6.8.5 Polaris Recent Development and Response to COVID-19
6.9 Auqi
6.9.1 Auqi Corporation Information
6.9.2 Auqi Description, Business Overview and Total Revenue
6.9.3 Auqi EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Auqi Products Offered
6.9.5 Auqi Recent Development and Response to COVID-19
7 EPA / DHA/ALA (Omega 3) Manufacturing Cost Analysis
7.1 EPA / DHA/ALA (Omega 3) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of EPA / DHA/ALA (Omega 3)
7.4 EPA / DHA/ALA (Omega 3) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 EPA / DHA/ALA (Omega 3) Distributors List
8.3 EPA / DHA/ALA (Omega 3) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Type (2021-2026)
10.2 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Application (2021-2026)
10.3 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Region (2021-2026)
10.4 North America EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
10.5 Europe EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
10.6 Asia Pacific EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
10.7 Latin America EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
10.8 Middle East and Africa EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global EPA / DHA/ALA (Omega 3) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global EPA / DHA/ALA (Omega 3) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global EPA / DHA/ALA (Omega 3) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four EPA / DHA/ALA (Omega 3) Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for EPA / DHA/ALA (Omega 3) Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for EPA / DHA/ALA (Omega 3) Players to Combat Covid-19 Impact
Table 9. Global Key EPA / DHA/ALA (Omega 3) Manufacturers Covered in This Study
Table 10. Global EPA / DHA/ALA (Omega 3) Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global EPA / DHA/ALA (Omega 3) Sales Share by Manufacturers (2015-2020)
Table 12. Global EPA / DHA/ALA (Omega 3) Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global EPA / DHA/ALA (Omega 3) Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market EPA / DHA/ALA (Omega 3) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers EPA / DHA/ALA (Omega 3) Sales Sites and Area Served
Table 16. Manufacturers EPA / DHA/ALA (Omega 3) Product Types
Table 17. Global EPA / DHA/ALA (Omega 3) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global EPA / DHA/ALA (Omega 3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPA / DHA/ALA (Omega 3) as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key EPA / DHA/ALA (Omega 3) Players
Table 21. Global EPA / DHA/ALA (Omega 3) Sales (K Units) by Region (2015-2020)
Table 22. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2015-2020)
Table 23. Global EPA / DHA/ALA (Omega 3) Revenue (Million US$) by Region (2015-2020)
Table 24. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Region (2015-2020)
Table 25. North America EPA / DHA/ALA (Omega 3) Sales by Country (2015-2020) (K Units)
Table 26. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2015-2020)
Table 27. North America EPA / DHA/ALA (Omega 3) Revenue by Country (2015-2020) (US$ Million)
Table 28. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2015-2020)
Table 29. Europe EPA / DHA/ALA (Omega 3) Sales by Country (2015-2020) (K Units)
Table 30. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2015-2020)
Table 31. Europe EPA / DHA/ALA (Omega 3) Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific EPA / DHA/ALA (Omega 3) Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific EPA / DHA/ALA (Omega 3) Revenue Market Share by Region (2015-2020)
Table 37. Latin America EPA / DHA/ALA (Omega 3) Sales by Country (2015-2020) (K Units)
Table 38. Latin America EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2015-2020)
Table 39. Latin America EPA / DHA/ALA (Omega 3) Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2015-2020)
Table 45. Global EPA / DHA/ALA (Omega 3) Sales (K Units) by Type (2015-2020)
Table 46. Global EPA / DHA/ALA (Omega 3) Sales Share by Type (2015-2020)
Table 47. Global EPA / DHA/ALA (Omega 3) Revenue (Million US$) by Type (2015-2020)
Table 48. Global EPA / DHA/ALA (Omega 3) Revenue Share by Type (2015-2020)
Table 49. Global EPA / DHA/ALA (Omega 3) Price (US$/Unit) by Type (2015-2020)
Table 50. Global EPA / DHA/ALA (Omega 3) Sales (K Units) by Application (2015-2020)
Table 51. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
Table 52. Global EPA / DHA/ALA (Omega 3) Sales Growth Rate by Application (2015-2020)
Table 53. EPAX EPA / DHA/ALA (Omega 3) Corporation Information
Table 54. EPAX Description and Business Overview
Table 55. EPAX EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. EPAX Main Product
Table 57. EPAX Recent Development
Table 58. Golden Omega EPA / DHA/ALA (Omega 3) Corporation Information
Table 59. Golden Omega Corporation Information
Table 60. Golden Omega EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Golden Omega Main Product
Table 62. Golden Omega Recent Development
Table 63. TASA EPA / DHA/ALA (Omega 3) Corporation Information
Table 64. TASA Corporation Information
Table 65. TASA EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. TASA Main Product
Table 67. TASA Recent Development
Table 68. Omega Protein EPA / DHA/ALA (Omega 3) Corporation Information
Table 69. Omega Protein Corporation Information
Table 70. Omega Protein EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Omega Protein Main Product
Table 72. Omega Protein Recent Development
Table 73. Croda EPA / DHA/ALA (Omega 3) Corporation Information
Table 74. Croda Corporation Information
Table 75. Croda EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Croda Main Product
Table 77. Croda Recent Development
Table 78. KD Pharma EPA / DHA/ALA (Omega 3) Corporation Information
Table 79. KD Pharma Corporation Information
Table 80. KD Pharma EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. KD Pharma Main Product
Table 82. KD Pharma Recent Development
Table 83. GC Rieber EPA / DHA/ALA (Omega 3) Corporation Information
Table 84. GC Rieber Corporation Information
Table 85. GC Rieber EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. GC Rieber Main Product
Table 87. GC Rieber Recent Development
Table 88. Polaris EPA / DHA/ALA (Omega 3) Corporation Information
Table 89. Polaris Corporation Information
Table 90. Polaris EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Polaris Main Product
Table 92. Polaris Recent Development
Table 93. Auqi EPA / DHA/ALA (Omega 3) Corporation Information
Table 94. Auqi Corporation Information
Table 95. Auqi EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Auqi Main Product
Table 97. Auqi Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. EPA / DHA/ALA (Omega 3) Distributors List
Table 101. EPA / DHA/ALA (Omega 3) Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global EPA / DHA/ALA (Omega 3) Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global EPA / DHA/ALA (Omega 3) Sales Market Share Forecast by Type (2021-2026)
Table 107. Global EPA / DHA/ALA (Omega 3) Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global EPA / DHA/ALA (Omega 3) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global EPA / DHA/ALA (Omega 3) Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global EPA / DHA/ALA (Omega 3) Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global EPA / DHA/ALA (Omega 3) Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global EPA / DHA/ALA (Omega 3) Sales Market Share Forecast by Region (2021-2026)
Table 113. Global EPA / DHA/ALA (Omega 3) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global EPA / DHA/ALA (Omega 3) Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of EPA / DHA/ALA (Omega 3)
Figure 2. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type: 2020 VS 2026
Figure 3. Fish Oil Product Picture
Figure 4. Algae Oil Product Picture
Figure 5. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Dietary Supplements
Figure 7. Functional Foods & Beverages
Figure 8. Others
Figure 9. Global EPA / DHA/ALA (Omega 3) Market Size 2015-2026 (US$ Million)
Figure 10. Global EPA / DHA/ALA (Omega 3) Sales Capacity (K Units) (2015-2026)
Figure 11. Global EPA / DHA/ALA (Omega 3) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. EPA / DHA/ALA (Omega 3) Sales Share by Manufacturers in 2020
Figure 13. Global EPA / DHA/ALA (Omega 3) Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by EPA / DHA/ALA (Omega 3) Revenue in 2019
Figure 15. EPA / DHA/ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2015-2020)
Figure 17. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Region in 2019
Figure 18. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Region (2015-2020)
Figure 19. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Region in 2019
Figure 20. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Country in 2019
Figure 21. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country in 2019
Figure 22. U.S. EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Country in 2019
Figure 27. Europe EPA / DHA/ALA (Omega 3) Revenue Market Share by Country in 2019
Figure 28. Germany EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 31. France EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Region in 2019
Figure 39. Asia Pacific EPA / DHA/ALA (Omega 3) Revenue Market Share by Region in 2019
Figure 40. China EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 41. China EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 47. India EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Latin America EPA / DHA/ALA (Omega 3) Sales Market Share by Country in 2019
Figure 51. Latin America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country in 2019
Figure 52. Mexico EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 53. Mexico EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Brazil EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 55. Brazil EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Argentina EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 57. Argentina EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Middle East and Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Country in 2019
Figure 59. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Country in 2019
Figure 60. Turkey EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 61. Turkey EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Saudi Arabia EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 63. Saudi Arabia EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. U.A.E EPA / DHA/ALA (Omega 3) Sales Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E EPA / DHA/ALA (Omega 3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Sales Market Share of EPA / DHA/ALA (Omega 3) by Type (2015-2020)
Figure 67. Sales Market Share of EPA / DHA/ALA (Omega 3) by Type in 2019
Figure 68. Revenue Share of EPA / DHA/ALA (Omega 3) by Type (2015-2020)
Figure 69. Revenue Market Share of EPA / DHA/ALA (Omega 3) by Type in 2019
Figure 70. Global EPA / DHA/ALA (Omega 3) Sales Growth by Type (2015-2020) (K Units)
Figure 71. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
Figure 72. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application in 2019
Figure 73. Global Revenue Share of EPA / DHA/ALA (Omega 3) by Application (2015-2020)
Figure 74. Global Revenue Share of EPA / DHA/ALA (Omega 3) by Application in 2020
Figure 75. EPAX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Golden Omega Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. TASA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Omega Protein Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Croda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. KD Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. GC Rieber Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Polaris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Auqi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Price Trend of Key Raw Materials
Figure 85. Manufacturing Cost Structure of EPA / DHA/ALA (Omega 3)
Figure 86. Manufacturing Process Analysis of EPA / DHA/ALA (Omega 3)
Figure 87. EPA / DHA/ALA (Omega 3) Industrial Chain Analysis
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Porter's Five Forces Analysis
Figure 91. North America EPA / DHA/ALA (Omega 3) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 92. North America EPA / DHA/ALA (Omega 3) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 93. Europe EPA / DHA/ALA (Omega 3) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 94. Europe EPA / DHA/ALA (Omega 3) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 95. Latin America EPA / DHA/ALA (Omega 3) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 96. Latin America EPA / DHA/ALA (Omega 3) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 97. Middle East and Africa EPA / DHA/ALA (Omega 3) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 98. Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 99. Asia Pacific EPA / DHA/ALA (Omega 3) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 100. Asia Pacific EPA / DHA/ALA (Omega 3) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs